Clinical Trials Directory

Trials / Completed

CompletedNCT05282641

Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health

Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health in Obese (BMI 25-35 kg/m2) Men and Women With Elevated Risk to Develop Type-2 Diabetes and CVD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

The effects of a 10g/day collagen hydrolysate for a period of 4 weeks on glycemic control and cardiovascular health in a parallel design study using overweight/ obese men and women who are likely to have a disturbed lipid and glucose metabolism and increased risk to develop cardiovascular disease and/or Type- 2 diabetes.

Detailed description

Food-derived bioactive peptides represent a source of health-enhancing components that have been reported to have cardiovascular health benefits in humans and may be incorporated in functional foods. Up till now studies using collagen hydrolysates particularly addressed issues around joint health, however, there are some preliminary indications that other health-related targets might be affected as well. We here propose to focus on the potential effects of collagen hydrolysates on glycemic control, and characteristics of the microcirculation, both important parameters for the assessment of future cardiovascular disease (CVD) risk.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT10 g of collagen hydrolysateBefore breakfast, participants consume 1 sachet every day for 4 weeks. The sachet contains 10-gram collagen protein hydrolysates + 5-gram erythritol and it has to be dissolved in 250 ml of water.
DIETARY_SUPPLEMENTPlaceboBefore breakfast, participants consume 1 sachet every day for 4 weeks. The sachet contains 5-gram erythritol (placebo) and has to be dissolved in 250 ml of water.

Timeline

Start date
2021-05-26
Primary completion
2023-08-24
Completion
2023-08-24
First posted
2022-03-16
Last updated
2023-11-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05282641. Inclusion in this directory is not an endorsement.